Cargando…
Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
Immune checkpoint blockade is less efficient in patients bearing immunologically ‘cold’ tumors. Oncolytic viruses, which were originally discovered for their ability to preferentially kill malignant cells, can recondition the tumor microenvironment. Supporting this hypothesis, two new studies publis...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136862/ https://www.ncbi.nlm.nih.gov/pubmed/30221036 http://dx.doi.org/10.1080/2162402X.2018.1442169 |
_version_ | 1783355081950756864 |
---|---|
author | Gujar, Shashi Pol, Jonathan G. Kroemer, Guido |
author_facet | Gujar, Shashi Pol, Jonathan G. Kroemer, Guido |
author_sort | Gujar, Shashi |
collection | PubMed |
description | Immune checkpoint blockade is less efficient in patients bearing immunologically ‘cold’ tumors. Oncolytic viruses, which were originally discovered for their ability to preferentially kill malignant cells, can recondition the tumor microenvironment. Supporting this hypothesis, two new studies published in Science Translational Medicine show that adjuvant-like activities of oncolytic viruses make brain and breast tumors ‘hot’ and sensitize them for subsequent immune checkpoint blockade. |
format | Online Article Text |
id | pubmed-6136862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-61368622018-09-14 Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies Gujar, Shashi Pol, Jonathan G. Kroemer, Guido Oncoimmunology Editorial Immune checkpoint blockade is less efficient in patients bearing immunologically ‘cold’ tumors. Oncolytic viruses, which were originally discovered for their ability to preferentially kill malignant cells, can recondition the tumor microenvironment. Supporting this hypothesis, two new studies published in Science Translational Medicine show that adjuvant-like activities of oncolytic viruses make brain and breast tumors ‘hot’ and sensitize them for subsequent immune checkpoint blockade. Taylor & Francis 2018-03-13 /pmc/articles/PMC6136862/ /pubmed/30221036 http://dx.doi.org/10.1080/2162402X.2018.1442169 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Editorial Gujar, Shashi Pol, Jonathan G. Kroemer, Guido Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title | Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title_full | Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title_fullStr | Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title_full_unstemmed | Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title_short | Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
title_sort | heating it up: oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136862/ https://www.ncbi.nlm.nih.gov/pubmed/30221036 http://dx.doi.org/10.1080/2162402X.2018.1442169 |
work_keys_str_mv | AT gujarshashi heatingituponcolyticvirusesmaketumorshotandsuitableforcheckpointblockadeimmunotherapies AT poljonathang heatingituponcolyticvirusesmaketumorshotandsuitableforcheckpointblockadeimmunotherapies AT kroemerguido heatingituponcolyticvirusesmaketumorshotandsuitableforcheckpointblockadeimmunotherapies |